We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
Cap. Flow
-$218M
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$125M
2
PRGO icon
Perrigo
PRGO
+$103M
3
AGN
Allergan plc
AGN
+$99.6M
4
PFE icon
Pfizer
PFE
+$90M
5
VTRS icon
Viatris
VTRS
+$88.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.63%
2 Healthcare 15.57%
3 Communication Services 13.26%
4 Technology 11.56%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.3B
$398M 3.84%
8,986,076
-404,538
-4% -$17.2M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.88T
$241M 2.32%
6,318,000
+2,101,780
+50% +$77.4M
TMUS icon
3
T-Mobile US
TMUS
$184B
$214M 2.06%
5,585,934
+81,674
+1% +$3.08M
CMCSA icon
4
Comcast
CMCSA
$78.3B
$161M 1.55%
5,261,792
-509,494
-9% -$14.6M
SHW icon
5
Sherwin-Williams
SHW
$76.6B
$158M 1.52%
1,660,572
+757,872
+84% +$66.3M
BKNG icon
6
Booking.com
BKNG
$134B
$141M 1.36%
2,736,825
+1,414,175
+107% +$67.7M
EL icon
7
Estee Lauder
EL
$28.9B
$125M 1.2%
1,324,526
+399,726
+43% +$35.6M
EMC
8
DELISTED
EMC CORPORATION
EMC
$121M 1.16%
4,522,876
+4,071,573
+902% +$103M
MSFT icon
9
Microsoft
MSFT
$2.83T
$119M 1.15%
2,161,481
+94,234
+5% +$4.94M
ADBE icon
10
Adobe
ADBE
$84.3B
$117M 1.12%
1,242,313
+1,215,739
+4,575% +$105M
LYB icon
11
LyondellBasell Industries
LYB
$19.9B
$114M 1.1%
1,329,498
-166,156
-11% -$13.3M
V icon
12
Visa
V
$669B
$110M 1.06%
1,441,542
+918,245
+175% +$66.7M
EEM icon
13
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$108M 1.04%
+3,149,620
New +$97.6M
HUM icon
14
Humana
HUM
$47.4B
$107M 1.03%
585,608
+414,600
+242% +$71.9M
CI icon
15
Cigna
CI
$75.7B
$96.1M 0.93%
700,502
+490,204
+233% +$67.3M
MDT icon
16
Medtronic
MDT
$105B
$95.2M 0.92%
1,269,291
+667,890
+111% +$50.3M
UHS icon
17
Universal Health Services
UHS
$9.16B
$94.5M 0.91%
757,658
+480,562
+173% +$54M
C icon
18
Citigroup
C
$221B
$90.2M 0.87%
2,160,364
+306,247
+17% +$12.8M
SBUX icon
19
Starbucks
SBUX
$118B
$89.5M 0.86%
1,499,878
+952,978
+174% +$55.5M
ORLY icon
20
O'Reilly Automotive
ORLY
$71.4B
$83.5M 0.8%
4,574,550
+1,569,930
+52% +$26.8M
AMZN icon
21
Amazon
AMZN
$2.51T
$82.3M 0.79%
2,771,580
+539,840
+24% +$15.3M
ALLE icon
22
Allegion
ALLE
$13.3B
$80.8M 0.78%
1,268,538
+262,455
+26% +$16M
BHI
23
DELISTED
Baker Hughes
BHI
$79M 0.76%
1,803,323
+1,255,103
+229% +$54.2M
RAD
24
DELISTED
Rite Aid Corporation
RAD
$72.1M 0.69%
442,079
+435,874
+7,025% +$68.7M
CVS icon
25
CVS Health
CVS
$136B
$67M 0.65%
646,231
+111,037
+21% +$10.8M

Similar funds

Marshall Wace's Q1 2016 Portfolio in Review

As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
  • Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
  • Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
  • Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
  • Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.